High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Makino
Aritaka
A
Department of Internal Medicine II, University of Yamanashi, Faculty of Medicine, Yamanashi, Japan.
Nakamura
Takamitsu
T
Hirano
Mitsumasa
M
Kitta
Yoshinobu
Y
Sano
Keita
K
Kobayashi
Tsuyoshi
T
Fujioka
Daisuke
D
Saito
Yukio
Y
Watanabe
Kazuhiro
K
Watanabe
Yosuke
Y
Kawabata
Ken-ichi
K
Obata
Jun-ei
JE
Kugiyama
Kiyotaka
K